Literature DB >> 9056213

An homogeneous fluorescence polymerase chain reaction assay to identify Salmonella.

S Y Tseng1, D Macool, V Elliott, G Tice, R Jackson, M Barbour, D Amorese.   

Abstract

We have developed a semiquantitative homogeneous fluorescence assay that combines polymerase chain reaction (PCR) amplification with direct fluorescence detection (HF-PCR). The assay eliminates the need to perform gel electrophoresis on test samples. Using a set of Salmonella-specific primers, this system was used to verify suspect colonies from culture plates as Salmonella. The fluorescence signal is generated by a nucleic acid dye, YO-PRO-1, that is included in the amplification reaction. This homogeneous PCR assay was used to test 84 Salmonella strains picked from selective culture plates. All data indicated positive results when compared with 17 non-Salmonella strains (in general, Citrobacter, Hafnia, Proteus, and Escherichia). The HF-PCR assay is a sensitive, simple, accurate, and reproducible method that correlates well with size-exclusion high-performance liquid chromatography and gel electrophoresis techniques as a means to monitor PCR-mediated DNA amplification. This assay can confirm suspect colonies within 2.5 h.

Entities:  

Mesh:

Year:  1997        PMID: 9056213     DOI: 10.1006/abio.1996.9970

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

Review 1.  Real-time PCR in virology.

Authors:  Ian M Mackay; Katherine E Arden; Andreas Nitsche
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

2.  A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples.

Authors:  Gillian Ellison; Emma Donald; Gael McWalter; Lucy Knight; Lynn Fletcher; James Sherwood; Mireille Cantarini; Maria Orr; Georgina Speake
Journal:  J Exp Clin Cancer Res       Date:  2010-10-06

Review 3.  Advances in real-time PCR: application to clinical laboratory diagnostics.

Authors:  Bernhard Kaltenboeck; Chengming Wang
Journal:  Adv Clin Chem       Date:  2005       Impact factor: 5.394

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.